With the coronavirus still wreaking havoc, vaccine stocks are in the spotlight.
To date, Gilead has noted preliminary results of a COVID-19 vaccine trial “showed...
Exciting earnings they’re not.
Lockheed Martin (LMT – Get Report) is getting attention this afternoon following the firm’s second-quarter earnings release. Lockheed earned $5 per...